Mid Continent Capital’s AbbVie ABBV Stock Holding History

Mid Continent Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$2.35M	Sell	43,188 -12,250	-22%	-$797K	0.15%	105
2015 Q2	$3.73M	Buy	55,438 +1,000	+2%	+$65.3K	0.21%	94
2015 Q1	$3.19M	Sell	54,438 -3,307	-6%	-$200K	0.18%	109
2014 Q4	$3.78M	Sell	57,745 -2,695	-4%	-$170K	0.22%	94
2014 Q3	$3.49M	Sell	60,440 -625	-1%	-$34.7K	0.2%	99
2014 Q2	$3.45M	Buy	61,065 +1,450	+2%	+$76.1K	0.2%	102
2014 Q1	$3.06M	Sell	59,615 -700	-1%	-$35.4K	0.18%	99
2013 Q4	$3.19M	Sell	60,315 -325	-0.5%	-$16K	0.2%	99
2013 Q3	$2.71M	Sell	60,640 -9,566	-14%	-$424K	0.19%	106
2013 Q2	$2.9M	Buy	+70,206	New	+$3.07M	0.21%	98

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Mid Continent Capital's ABBV Position: Q3 2015 in Review

Mid Continent Capital reduced its AbbVie (ABBV) stake by 22% in Q3 2015, selling an estimated $797K and leaving 43,188 shares worth $2.35M. The position accounts for 0.15% of the portfolio, ranked #105.

Mid Continent Capital first reported a position in ABBV in Q2 2013 and has held it in 10 quarters since. The position peaked at $3.78M in Q4 2014. 1,604 funds tracked by Wall St. Rank hold ABBV as of Q3 2015.

Mid Continent Capital held 43,188 shares of AbbVie worth $2.35M as of Q3 2015.
Mid Continent Capital sold 12,250 AbbVie shares in Q3 2015, an estimated $797K.
AbbVie made up 0.15% of Mid Continent Capital's portfolio in Q3 2015, its #105 holding.
Mid Continent Capital first reported a position in AbbVie in Q2 2013 and has held it in 10 quarters since.
Mid Continent Capital's AbbVie position peaked at $3.78M in Q4 2014.
1,604 funds tracked by Wall St. Rank held AbbVie as of Q3 2015.

Based on Mid Continent Capital's 13F filing for Q3 2015, filed 22 Oct 2015.